Modified neuraminidase
US-12577570-B2 · Mar 17, 2026 · US
This page is not indexed by search engines while we improve data quality.
Carboxypeptidase C (3.4.16.5), i.e. carboxypeptidase Y
Carboxypeptidase C (3.4.16.5), i.e. carboxypeptidase Y · Cooperative Patent Classification (CPC)
Chemical and metallurgical processes, compounds, and materials.
Related technology areas
Mapped technology topics for this CPC code.
| Metric | Value |
|---|---|
| CPC code | C12Y304/16005 |
| Official title | Carboxypeptidase C (3.4.16.5), i.e. carboxypeptidase Y |
| Display label | Carboxypeptidase C (3.4.16.5), i.e. carboxypeptidase Y |
| Total patents | 19 |
Filing trend
Year-over-year patent counts classified under this CPC code.
Filing activity over the last five years is declining.
| Year | Patents |
|---|---|
| 2015 | 2 |
| 2016 | 1 |
| 2018 | 3 |
| 2019 | 1 |
| 2020 | 3 |
| 2021 | 3 |
| 2022 | 2 |
| 2023 | 1 |
| 2025 | 2 |
| 2026 | 1 |
Representative patents
Representative publications under this CPC code from precomputed stats, or recent filings when stats are unavailable.
Compositions and methods for treating sialidosis
US-2025135033-A1 · May 1, 2025 · US
Peptide therapeutics for treating Alzheimer's disease and related conditions
US-12241099-B2 · Mar 4, 2025 · US
Plant milk treated with protein deamidase
US-2023240312-A1 · Aug 3, 2023 · US
Methods of treating dementia associated with alzheimer's disease with protective protein/cathepsin a (ppca)
US-2022406435-A1 · Dec 22, 2022 · US
Modified neuraminidase
US-2022364101-A1 · Nov 17, 2022 · US
Proline specific endopeptidases
US-2021315238-A1 · Oct 14, 2021 · US
Engineered cells with modified host cell protein profiles
US-2021238628-A1 · Aug 5, 2021 · US
Peptide therapeutics for treating alzheimer's disease and related conditions
US-2021115426-A1 · Apr 22, 2021 · US
Thermophile-derived keratinase and use thereof
US-10612010-B2 · Apr 7, 2020 · US
Methods of treating dementia associated with alzheimer's disease with protective protein/cathepsin a (ppca)
US-2020087704-A1 · Mar 19, 2020 · US
Methods of treating dementia associated with Alzheimer's disease with protective protein/cathepsin A (PPCA)
US-10533208-B2 · Jan 14, 2020 · US
Reduction of lipase activity in product formulations
US-2019390203-A1 · Dec 26, 2019 · US
Reduction of lipase activity in product formulations
US-2018179545-A1 · Jun 28, 2018 · US
Reduction of lipase activity in product formulations
US-9932591-B2 · Apr 3, 2018 · US
Methods and compositions to detect the level of lysosomal exocytosis activity and methods of use
US-2018057854-A1 · Mar 1, 2018 · US
Reduction of lipase activity in product formulations
US-2016312226-A1 · Oct 27, 2016 · US
Pharmaceutical composition for treating lysosomal storage disease
US-9138465-B2 · Sep 22, 2015 · US
Method for Producing an Acidified Milk Drink
US-2015030723-A1 · Jan 29, 2015 · US